Lue, Tom F.

Oral Sildenafil in the Treatment of Erectile Dysfunction

Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 2,120

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil

Padma-Nathan, H., Hellstrom, W. J. G., Kaiser, F. E., Labasky, R. F., Lue, T. F., Nolten, W. E., Norwood, P. C., Peterson, C. A., Shabsigh, R., Tam, P. Y., et al. (1997) · New England Journal of Medicine

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 574

Brain activation and sexual arousal in healthy, heterosexual males

Arnow, B. A., Desmond, J. E., Banner, L. L., Glover, G. H., Solomon, A., Polan, M. L., Lue, T. F., & Atlas, S. W. (2002) · Brain

Sexual function and dysfunction studiesSexuality, Behavior, and Technology

Cited by 425

Defining stem and progenitor cells within adipose tissue

Lin, G., Garcia, M., Ning, H., Banie, L., Guo, Y.-L., Lue, T. F., & Lin, C.-S. (2008) · Stem Cells and Development

Mesenchymal stem cell researchAdipose Tissue and Metabolism

Cited by 398

PEYRONIE'S DISEASE IS ASSOCIATED WITH AN INCREASE IN TRANSFORMING GROWTH FACTOR-beta PROTEIN EXPRESSION

El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology

Dupuytren's Contracture and TreatmentsUrological Disorders and Treatments

Cited by 250

Is CD34 truly a negative marker for mesenchymal stromal cells?

Lin, C.-S., Ning, H., Lin, G., & Lue, T. F. (2012) · Cytotherapy

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 239

Risk Factors for Emotional and Relationship Problems in Peyronie's Disease

Smith, J. F., Walsh, T. J., Conti, S. L., Turek, P., & Lue, T. (2008) · The Journal of Sexual Medicine

Sexual function and dysfunction studiesDupuytren's Contracture and Treatments

Cited by 206

Impact of Peyronie's Disease on Sexual and Psychosocial Functioning: Qualitative Findings in Patients and Controls

Rosen, R., Catania, J., Lue, T., Althof, S., Henne, J., Hellstrom, W., & Levine, L. (2008) · The Journal of Sexual Medicine

Sexual function and dysfunction studiesDupuytren's Contracture and Treatments

Cited by 197

Health issues of men: prevalence and correlates of erectile dysfunction

SHABSIGH, R., PERELMAN, M. A., LOCKHART, D. C., LUE, T. F., & BRODERICK, G. A. (2005) · Journal of Urology

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 126

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

Hellstrom, W. J. G., Bennett, A. H., Gesundheit, N., Kaiser, F. E., Lue, T. F., Padma-Nathan, H., Peterson, C. A., Tam, P. Y., Todd, L. K., Varady, J. C., et al. (1996) · Urology

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 76

Treatment Options for Erectile Dysfunction

Brant, W. O., Bella, A. J., & Lue, T. F. (2007) · Endocrinology and Metabolism Clinics of North America

Sexual function and dysfunction studiesUrological Disorders and Treatments

Cited by 51

Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-β 1 in Peyronie's disease

Lin, C.-S., Lin, G., Wang, Z., Maddah, S. A., & Lue, T. F. (2002) · Biochemical and Biophysical Research Communications

Dupuytren's Contracture and TreatmentsUrological Disorders and Treatments

Cited by 45

Peyronie's disease: an anatomically-based hypothesis and beyond

Lue, T. F. (2002) · International Journal of Impotence Research

Dupuytren's Contracture and TreatmentsUrological Disorders and Treatments

Cited by 42

Three important components in the regeneration of the cavernous nerve: brain-derived neurotrophic factor, vascular endothelial growth factor and the JAK/STAT signaling pathway.

Zhang, H.-Y., Jin, X.-B., & Lue, T. F. (2011) · Asian Journal of Andrology

Nerve injury and regenerationSexual function and dysfunction studies

Cited by 39